Background {#Sec1}
==========

Vaccination is considered as one of the biggest achievements of the twentieth century and as one of the most cost effective measures in the prevention of childhood diseases \[[@CR1]\]. In 1974, the World Health Organization (WHO) launched a worldwide vaccination program known as the Expanded Program of Immunization (EPI), which has been considered one of the major public health interventions aimed at reducing infant morbidity and mortality \[[@CR2]\]. During the launching of the EPI in 1976, only about 5% of infants throughout the world were protected against six diseases (diphteria, measles, pertussis, poliomyelitis, tetanus, and tuberculosis). By 2013, the number of protected infants was more than 80% in many countries. It is estimated that vaccination helps to prevent 2 to 3 million infant deaths each year \[[@CR3]\].

The Expanded Program of Immunization started in Cameroon in 1976 as a pilot project and targeted infants from 0 to 11 months. Initially it targeted 6 diseases (diphtheria, measles, pertussis, poliomyelitis, tetanus, and tuberculosis), and other vaccines were gradually introduced; the last to be introduced in the EPI was IPV in 2015. Presently, it has vaccines against the following diseases: tuberculosis, diphteria, tetanus, poliomyelitis, pertussis, viral hepatitis B, type b Hemophilus influenza infections, pneumococcal infections, diarrhoea caused by rotavirus, measles, yellow fever, and rubeola. An infant is completely immunized when he or she has received all the vaccines in the EPI. Ensuring that all the doses are not only administered, but given at the appropriate ages, is of crucial importance in ensuring the efficacy of the vaccine in disease prevention \[[@CR4]\]. An infant is correctly vaccinated when he or she has received all the vaccines at the recommended ages. Many infants still do not complete their vaccination schedules or are vaccinated after the recommended ages \[[@CR5], [@CR6]\].

Given the importance of vaccination in reducing morbidity and mortality in children, we decided to assess the completeness and timeliness of immunization and its determinants at the Yaounde Gyneco-Obstetric and Pediatric hospital, which is a tertiary mother and child hospital in Cameroon. This will ultimately improve the vaccine coverage and reduce obstacles which might hinder effective implementation.

Methods {#Sec2}
=======

A cross-sectional analytical study was conducted; over a period of 3 months (1st February to 30th April 2016) in the vaccination unit of the Yaounde Gyneco-Obstetric and Pediatric Hospital (YGOPH), which is a mother and child referral hospital in Yaounde, the capital city of Cameroon. All mothers of infants aged 0 to 11 months coming for routine EPI were enrolled in the study.

Pre-tested questionnaires were filled for all mother-infant pairs at the vaccination unit, after obtaining consent from the mothers or caretakers of the infants (see Additional file [1](#MOESM1){ref-type="media"}). Information collected on the infants included age, sex, place of birth, place of first vaccination, the usual vaccination site, vaccines received, and date of vaccination for each antigen received.

Information concerning the parents included: age, level of education, profession, marital status, religion, region of origin, distance from the house to the vaccination unit, satisfaction from vaccination unit as expressed by the mothers or caretakers. The cut offs of 30 years for the mothers' age and a distance of 5 km, was used in our analysis; same cut offs were used by Hu et al. \[[@CR6]\]. The mothers or the caretakers of the infants were first interviewed and then the vaccination booklets of the infants they came with examined (to minimize recall bias); to verify the vaccines received and the dates they were administered.
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where z is the significance threshold;1.96 for a 95% confidence level, d is the error margin; 5%, and p; 64.3%, is the prevalence of vaccine completeness from the study of Ba Pouth et al. \[[@CR5]\] in the Djoungolo health district in 2012.

Definition of variables {#Sec3}
=======================

The dependent variables were the immunization completeness, and the antigen specific immunization coverage of children aged 0 to 11 months.

An infant was considered as being completely vaccinated if he/she had received all of the doses of the following vaccines: BCG, OPV~0~, DTP-HepB~1~-Hib1, OPV~1~, Rota~1~, Pneumo13~1~, DTP-HepB~1~-Hib~2~, OPV~2~, Rota~2~, Pneumo13~2~, DTC-HepB~1~-Hib~3~, OPV~3~, Pneumo13~3~, Measles, Yellow fever and Rubeola vaccines according to the EPI schedule.

The immunization coverage per antigen was defined by the ratio of infants that received the antigen divided by the total number of infants sampled.

Immunization timeliness was defined as being vaccinated at the recommended ages. A period of 2 weeks was considered above which the vaccine was considered as delayed. Any child with delayed administration of one or more antigens was considered not timely vaccinated.

The independent variables were the different socio-demographic characteristics of our sample population. The outcomes were immunization completeness and timeliness.

Data analysis {#Sec4}
-------------

Data analysis was done using SPSS version 20.0 for windows. The data input control permitted the minimization of errors. The analysis of factors associated to vaccination completeness was done using the 'backwards' model of multivariate logistic regression. Logistic regression was first done to obtain the crude odds ratio for each of these factors with their 95% confidence intervals and their *P*-values. Thereafter the variables with a *p*-value \<0.2 were all entered in a model of multivariate logistic regression to control the confounding factors and determine which characteristics were independent predictors of the immunization completeness of the child. A p-value \<0.05 and an adjusted odds ratio (AOR) with its 95% confidence interval not containing 1.00 was considered significant.

Ethical considerations {#Sec5}
----------------------

Prior to carrying out this study, administrative authorization and ethical clearance was obtained from the Yaounde Gynaeco-Obstetric and Pediatric hospital and the Faculty of Medicine and Biomedical Sciences of the University of Yaounde I respectively. A written consent form was signed by each mother or caretaker who accepted to be enrolled and participate in the study, and for those who could not read and write verbal consent was sought after receiving information on the study. Participants in the study were informed on any missed vaccine and any other information concerning the child's vaccinations. All infants with vaccinations not up-to -date were vaccinated as recommended.

Results {#Sec6}
=======

Socio-demographic characteristics of the study population. {#Sec7}
----------------------------------------------------------

Overall, there were 415 mothers eligible for the study, and 15 were excluded (10 did not consent to participate and 5 did not have vaccination booklets). A total of 400 mother-infant pairs were sampled, of which 203 (51%) were females and 197 (49%) males; giving a sex ratio of 0.97. The median age for the infants was 98 days (range 1 day to 266 days). Most mothers (56.5%) were less than 30 years, 61.3% had secondary education, 79% were married and 50.3% lived at more than 5 km from the vaccination site (see Table [1](#Tab1){ref-type="table"}). Almost all the fathers (94.8%) had at least secondary school education and 38.8% worked in the informal sector (see Table [2](#Tab2){ref-type="table"}).Table 1Vaccination schedule for children aged 0--11 months in Cameroon \[[@CR20]\]ContactsAgeVaccineRoute of administrationPreventable diseases1st contactAt birthBCGIntradermalTuberculosisOPV 0OralPoliomyelitis2nd contact6 weeksDTP-HepB-Hib 1IntramuscularDiphteria, Tetanus,\
Pertussis,Infection due to\
Haemophilus Influenzae\
type b, Hepatitis BOPV 1OralPoliomyelitisPneumo 13--1\
(PCV)IntramuscularPneumococcal infectionsROTA 1OralRotavirus Diarrhoea3rd contact10 weeksDTP-HepB-Hib 2IntramuscularDiphteria, Tetanus,\
Pertussis,Infection due to\
Haemophilus Influenzae\
type b, Hepatitis BOPV 2OralPoliomyelitisPneumo 13--2\
ROTA 2Intramuscular\
OralPneumococcal infections\
Rotavirus Diarrhoea4th contact14 weeksDTP-HepB-Hib 3IntramuscularDiphteria, Tetanus,\
Pertussis,Infection due to\
Haemophilus Influenzae\
type b, Hepatitis BOPV 3\
IPVOral\
IntramuscularPoliomyelitisPneumo 13--3IntramuscularPneumococcal infections5th contact6 to 11\
monthsVit AOralAt 9 monthsMRSubcutaneousMeasles, RubellaYFSubcutaneousYellow fever Table 2Socio-demographic characteristics of the parentsVariablesNumberPercentage (%)Mother's age (years)\< 3022656.5≥ 3017443.5Mother's level of educationIlliterate41.0Primary328.0Secondary20561.3Higher15939.8Mother's professionPrivate5012.5Public servant5914.8Informal8521.3Pupil or student6917.3Unemployed13734.3Matrimonial statusSingle8421.0Couple31679.0ReligionChristian36791.8Muslim317.8Others20.5ParityPrimipara14536.3Multipara25563.8Distance from home to the vaccination unit (Km)\< 519949.8≥ 520150.3Satisfaction with the vaccination unitYes33383.3No6716.8Father's level of educationIlliterate20.5Primary194.8Secondary16641.5Higher21353.3Father's professionPrivate9323.3Public servant11629.0Informal15538.8Pupil or student256.3Unemployed112.8

Immunization completeness {#Sec8}
-------------------------

Of the 400 infants, immunization was complete in 96.3% of them. Amongst the infants who had completed their vaccination, 75.0% were born at the YGOPH, 90.0% of them started their vaccinations there and 87.0% regularly received their vaccines there. The immunization coverage for BCG, DTP~3~, Polio~3~ and measles were 99.8%, 93.3%, 93.3% and 100% respectively.

Vaccine coverage for each antigen is presented in Table [3](#Tab3){ref-type="table"}, and the rates are greater than 90% for each antigen. The measles and yellow fever vaccines had the highest coverage of 100%.Table 3Vaccination coverage and timely administration per antigenVaccinesVaccines received\
n^a^(%)Vaccines received timely\
n^c^(%)BCG + Polio 0 (N^b^ = 400)399 (99.8)332 (83.2)Vaccines at 6 weeks (N^b^ = 366)360 (98.4)340 (94.4)Vaccines at 10 weeks (N^b^ = 269)261 (97.0)249 (95.4)Vaccines at 14 weeks (N^b^ = 208)194 (93.3)182 (93.8)^a^number of children who received the vaccine^b^total number of children at the age to receive the vaccine^c^number of children who received the vaccine on timeVaccines scheduled at 6 weeks = DTP-HepB-Hib~1~, Pneumo13~1~, Rota~1~, Polio ~1~; Vaccines scheduled at 10 weeks = DTP-HepB-Hib~2~, Pneumo13~2~, Rota~2~, Polio~2~; Vaccines scheduled at 14 weeks = DTP-HepB-Hib~3~, Pneumo13~3~, Polio~3~

Immunization timeliness {#Sec9}
-----------------------

We noted that 73.3% of the children were fully vaccinated. The antigen-specific timeliness was 83.2% for BCG, 93.9% for DTP1 and 94.8% for the measles vaccine. The most delayed vaccines were the BCG, IPV and Pneumo13~3~.

Determinants of immunization completeness {#Sec10}
-----------------------------------------

The mother's level of education (secondary or higher level of education) and the father's profession influenced positively the immunization completeness (Table [4](#Tab4){ref-type="table"}). On bivariate and multivariate analysis, the same determinants: mother's level of education and the father's profession increased the infant's chances of immunization completeness (Table [4](#Tab4){ref-type="table"}).Table 4Determinants of immunization completenessVariablesImmunization completenessUnadjusted\
OR (95% CI)Unadjusted *P* valueAdjusted OR (95% CI)Adjusted *P* valueYesNoMother's age  \< 30 years219(96.9)7(3.1)1.51(0.54-4.24)0.43  ≥ 30 years166(95.4)8(4.6)Mother schooled to the higher level^a^ Yes354(97.3)10(2.7)5.71(1.84-17.76)0.0077.0(2.16-22.68)0.001 No31(86.1)5(13.9)Profession Employed251(95.4)12(4.6)0.47(0.13-1.69)0.24 Unemployed134(97.8)3(2.2)Matrimonial status Single81(96.4)3(3.6)1.07(0.29-3.87)1.00 Married304(96.2)12(3.8)Religion Christian352(95.9)15(4.1)/0.62 Muslim33(100)0(0.0)Parity Primipara139(96.5)5(3.5)1.13(0.38-3.37)0.83 Multipara246(96.1)10(3.9)Father schooled to the higher level^a^ Yes365(96.3)14(3.7)1.34(0.16--10.41)0.56 No20(95.2)1(4.8)Father's profession Employed378(96.7)13(3.3)8.31(1.57-43.95)0.0412.39(2.21-69.26)0.004 Unemployed7(77.8)2(22.2)^a^secondary + university education levels

Determinants of immunization timeliness {#Sec11}
---------------------------------------

Term babies, born at the YGOPH and who were regularly vaccinated there had better chances of being correctly vaccinated. After logistic regression analysis, only term babies had the greatest chance of being correctly vaccinated at the recommended ages (Table [5](#Tab5){ref-type="table"}).Table 5Determinants of immunization timelinessVariablesTimelinessUnadjusted\
OR (95% CI)Unadjusted *P* valueAdjusted OR\
(95% CI)Adjusted\
*P* valueAgeYesNo  \< 30 years165 (73)61 (27)0.9 (0.6--1.5)0.9  \> 30 years128 (76.6)46 (26.4)Level of education None/Primary26 (72.2)10 (27.8)0.9 (0.4--2)0.9 Secondary/Higher267 (73.4)97 (26.6)Mother's profession Employed192 (73)71 (27)0.9 (0.6--1.5)0.9 Unemployed101 (73.7)36 (26.3)Matrimonial status Single65 (77.4)19 (22.6)1.3 (0.7--2.3)0.3 Couple228 (72.2)88 (27.8)Religion Christian239 (73.3)98 (26.7)1 (0.5--2.3)0.9 Muslim24 (72.7)9 (27.3)Parity Primipara105 (72.9)39 (27.1)0.9 (0.6--1.5)0.9 Multipara188 (73.4)68 (26.6)Distance from home to vaccination unit  \< 5 Km149 (74.9)50 (25.1)1.2 (0.8--1.8)0.5  \> 5 Km144 (71.6)57 (28.4)Father's profession Employed287 (73.4)104 (26.6)1.4 (0.3--5.6)0.7 Unemployed6 (66.7)3 (33.3)Place of birth YGOPH221 (75.9)70 (24.1)1.6 (1.01--2.6)0.041.01 (0.9--3.3)1 Others72 (66.1)37 (33.9)Gestation age Term286 (81)67 (19)24.4 (10.5--56.8)**\<** 0.00119.3 (8.1--46.1)\< 0.001 Premature7 (14.9)40 (85.1)Place vaccination started YGOPH261 (74.8)88 (25.2)1.8 (0.9--3.3)0.07 Others32 (62.7)19 (37.3)Usual place of vaccination YGOPH252 (75.2)83 (24.8)1.8 (1.01--3.1)0.042.1 (0.9--4.6)0.08 Others41 (63.1)24 (36.9)

No factor related to the mother or father had a statistically significant relationship with immunization timeliness.

Discussion {#Sec12}
==========

An immunization completeness rate of 96.3% was noted. In South Africa, Fadnes et al. \[[@CR7]\] in 2011 had a rate of 94%, similar to ours. In Turkey, Torun et al. \[[@CR8]\] had a rate of 84.5%, Bofarraj et al. \[[@CR9]\] recorded a completeness rate of 81%. Other studies had rates which were much lower than ours: Ba Pouth et al. in 2012 in Cameroon(64.3%) \[[@CR5]\], Barreto et al. \[[@CR10]\] in Brazil (47%), Chidiebere et al. \[[@CR11]\] in Nigeria (30.6%), and 24.3% for Lakew et al. in Ethiopia \[[@CR12]\]. These differences could be explained by the fact that these studies were done in communities and on age ranges different from ours. They worked on infants aged 12 to 23 months while we worked on infants aged 0 to 11 months.

The immunization coverage for BCG, DTP~3~, OPV~3~ and the measles vaccine \[[@CR6]\] were 99.5%, 97.18%, 97.18% and 97.91% respectively. Similar figures were noted by Hu et al. in China, 90.16%, 91.63%, 92.70% respectively for DTP~3~, OPV~3~ and the measles vaccine. In Turkey, Ozcirpici et al. \[[@CR13]\] noted lower rates, 76.7%, 62%, 62% and 62.7% for BCG, DTP~3~, OPV~3~ and measles vaccine respectively.This could be explained by the fact that they worked on larger samples. Lower rates were equally noted by Mohamud et al. \[[@CR14]\], in Ethopia with an observed completeness rate for BCG, DTP~3~, OPV~3~ and measles vaccine of 41.8%, 41.1%, 41.1% and 24.9% respectively. This difference could be due to the fact that they worked in rural areas.

The father's profession had a statistically significant relationship with immunization completeness. This relationship persisted after multivariate analysis. Although the vaccines of the EPI are free, there are indirect costs such as transport fees to vaccination sites. If the father is working, these indirect costs could easily be covered; as in the African context, the father is directly responsible for the needs and health of the entire family \[[@CR15]\].

For the mother, only the level of education significantly influenced immunization completeness. This association was also found by Gidado et al. in Nigeria \[[@CR16]\], Ozcirpici et al. in Turkey \[[@CR13]\], Mohamud et al. in Ethiopia \[[@CR14]\] and Hu et al. en China \[[@CR6]\]. In Yaounde the level of scholarization is 94.3%, and ranks highest amongst all the regions of the country \[[@CR17]\]. A litterate woman will better understand messages on vaccination during educational talks, and this increases her awareness of the importance of vaccination. In China, Hu et al. \[[@CR6]\] found a significant relationship between the mother's age, her profession and immunization completeness. In Nigeria, the mothers's knowledge on vaccination, prenatal care, and information on vaccination, had a positive influence on immunization completeness \[[@CR16]\], whereas only the mother's age was a significant factor, in Ethiopia \[[@CR14]\].

No statistically significant association was found between any of the infant's variables with immunization completeness. However, the place of birth influenced immunization completeness in some studies \[[@CR6], [@CR14]\]. It is likely that when a child is born in a hospital, the mother is counseled on maternity and on the care of her baby, and especially on the vaccination schedule.

We observed in our study that 73.3% of the infants were correctly vaccinated. Rates of 88%, 56% and 50%, have been noted respectively in South Africa \[[@CR7]\], New Zealand \[[@CR18]\], and in the United States \[[@CR19]\]. These differences could be explained by the differences in the study sites, sample sizes and study design used. Infants not immunized at the recommended immunization ages have reduced immunity, conducive for development of diseases.

The antigen-specific timeliness was 83.2% for BCG, 93.9% for DTP~1~ and 94.8% for the measles vaccine. Similar figures have been noted by some authors: BCG (99%), DTP~1~ (87%) and measles vaccine (85%) \[[@CR7]\]; while others had lower figures, 44.59%, 45.38% and 59.25% respectively for BCG, DTP~1~ and measles vaccine \[[@CR6]\].

Children born at term, at the YGOPH, and who were regularly receiving their vaccines there, were more likely to be well vaccinated at the recommended ages. Premature neonates often have to wait untill they are medically stable before starting vaccinations, and this could explain the delay in starting vaccination at the recommended postnatal ages. Besides, children born in the YGOPH and who are regularly vaccinated there, receive more counselling than the others. In China, Hu et al. noted that timeliness of vaccination for specific vaccines was associated with the mother's age, maternal education level, immigration status, siblings, birth place and distance from the house to the immunization clinic \[[@CR6]\]. In South Africa, Fadnes et al. found, the level of education of the mother and the socio-economic status of the parents \[[@CR7]\], to be determinants of immunization timeliness.

The fact that the study was done in a single site, which was the vaccination unit of a referral hospital, and in an urban setting in which most mothers are well educated constitutes major limitations of this study. The results might not neccessarily reflect the vaccination status of the entire Yaounde community or Cameroon at large.

Conclusion {#Sec13}
==========

This study shows that immunization completeness was quite high but the number of children correctly vaccinated was relatively low. We suggest that more sensitization campaigns be done so as to enlighten parents on the importance of vaccination and on the importance of vaccinating children at the recommended ages.

Additional file {#Sec14}
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BCG

:   Bacille de Calmette et Guérin

DTP
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EPI
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HepB
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IPV
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OPV

:   Oral polio vaccine

PCV 13
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Polio

:   Poliomyelitis
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